These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Report on experiences with the complex treatment of cerebral and peripheral circulatory disorders]. Basarab A Med Welt; 1973 Apr; 24(16):650-2. PubMed ID: 4756330 [No Abstract] [Full Text] [Related]
23. [Drug therapy of cerebrovascular and cardiac insufficiency]. Kief W; Schmidt-Modrow G Med Welt; 1977 Oct; 28(42):1730-2. PubMed ID: 337039 [No Abstract] [Full Text] [Related]
24. [On the therapy of central and peripheral blood circulation disorders]. Weihrauch H Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064 [No Abstract] [Full Text] [Related]
25. [Use of pikamilon in the combined treatment of patients with cerebral circulatory disorders]. Zinchenko VA; Popov EA; Kalinichev SN; Lobzhanidze PV Vrach Delo; 1988 Dec; (12):18-9. PubMed ID: 3245153 [No Abstract] [Full Text] [Related]
26. [Mental effects of Wallerox therapy in the aged]. Thomae H Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216 [No Abstract] [Full Text] [Related]
27. [Wallerox increases cerebral circulation and heart capacity]. Heynen U Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212 [No Abstract] [Full Text] [Related]
28. [Muscular clearance of xenon (Xe-133) as a measure of the effectiveness of Provasan and Bametan for the correction of blood flow in the lower limbs]. Jonderko G; Szramek-Urbaniak A; Lewandowski J Pol Tyg Lek; 1981 Jan; 36(3):103-6. PubMed ID: 6113581 [No Abstract] [Full Text] [Related]
29. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy]. Blasi A; Licciardello M Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194 [No Abstract] [Full Text] [Related]
30. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies]. Leube H; Schwaeppe C Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138 [No Abstract] [Full Text] [Related]
31. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy]. D'Ayala Valva G Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405 [No Abstract] [Full Text] [Related]
32. [Comparative effects of sodium nicotinate and dihydroergotamine on cerebral circulation. Rheographic studies in subjects with cerebral vascular diseases]. Arrigo F; Turiano S; Consolo F Boll Soc Ital Biol Sper; 1973 Mar; 49(5):292-7. PubMed ID: 4786565 [No Abstract] [Full Text] [Related]
33. [Effects of a bamethan-inositol nicotinate combination on psycho-organic disease in the elderly]. Giaretti R; Astengo F; Astengo D; Coviello L; Fuliano P; Giaretti G; Melga P Clin Ter; 1982 Jan; 100(2):157-65. PubMed ID: 6137308 [No Abstract] [Full Text] [Related]
34. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine]. Cosmi F; Caresia L; Panebianco G Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528 [No Abstract] [Full Text] [Related]
35. [Possibilities of inspecting the action of drugs on the circulatory system]. Gros C; Weill J; Vrousos C; Turpel A J Radiol Electrol Med Nucl; 1967; 48(1):97-8. PubMed ID: 6030146 [No Abstract] [Full Text] [Related]
36. [On the importance of cerebral blood flow disorders in advanced age and their therapy]. Daniekczyk W; Weiler G Ther Ggw; 1967 Jan; 106(1):107-15. PubMed ID: 6043572 [No Abstract] [Full Text] [Related]
37. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit). Hentzer E Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834 [No Abstract] [Full Text] [Related]
38. [Inositol hexanicotinate and its cholesteropenic effect]. Crotte Zamora A; Romo López O Prensa Med Mex; 1974; 39(5-6):287-93. PubMed ID: 4612506 [No Abstract] [Full Text] [Related]
39. [Use of bamethan in the emergency treatment of cerebral disorders]. Lotto A; Cantono GM; Cavallaro GF Arch Sci Med (Torino); 1971; 128(4):210-20. PubMed ID: 4404000 [No Abstract] [Full Text] [Related]
40. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance]. Nedjabat T; Ebinger H; Birtel FJ Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]